From Medscape HIV/AIDS

Coverage from the

Conference on Retroviruses and Opportunistic Infections (CROI) 2022 Annual Meeting

February 12 - 16, 2022; Denver, CO and Virtual

February 12 - 16, 2022 Denver, CO and Virtual

Conference News

Popular News from CROI 2021

  • Lenacapavir Effective in Multidrug Resistant HIV Lenacapavir Effective in Multidrug Resistant HIV Some observers expressed skepticism, noting that reduced viral load may have resulted not from lenacapavir but a simultaneous switch to an optimized backbone regimen.
  • HIV Remission Approach Shows 'Signal' of Success HIV Remission Approach Shows 'Signal' of Success ART-free remission for people living with HIV may be possible, but this early trial will need to be tested in a larger group and in combination with other agents.
  • HIV PrEP: Annual Implant Moves Closer to the Clinic HIV PrEP: Annual Implant Moves Closer to the Clinic In communities most vulnerable to HIV, preexposure prophylaxis (PrEP) could fill the gap. Early data suggest a "fit it and forget it" implant could offer annual protection.

Medscape HIV/AIDS© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage